CapsoVision, Inc. (NASDAQ:CV – Get Free Report) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 357,735 shares, an increase of 281.0% from the January 15th total of 93,892 shares. Currently, 0.8% of the shares of the company are short sold. Based on an average daily volume of 468,270 shares, the short-interest ratio is presently 0.8 days. Based on an average daily volume of 468,270 shares, the short-interest ratio is presently 0.8 days. Currently, 0.8% of the shares of the company are short sold.
Hedge Funds Weigh In On CapsoVision
A number of hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC raised its position in shares of CapsoVision by 34.1% during the 4th quarter. Geode Capital Management LLC now owns 154,264 shares of the company’s stock valued at $1,649,000 after buying an additional 39,231 shares during the period. State Street Corp raised its holdings in shares of CapsoVision by 340.7% in the 4th quarter. State Street Corp now owns 85,929 shares of the company’s stock valued at $919,000 after purchasing an additional 66,429 shares in the last quarter. Citadel Advisors LLC purchased a new stake in shares of CapsoVision during the 3rd quarter worth $115,000. New York State Common Retirement Fund purchased a new position in CapsoVision in the third quarter valued at $34,000. Finally, Wells Fargo & Company MN lifted its holdings in CapsoVision by 66.4% during the 4th quarter. Wells Fargo & Company MN now owns 6,287 shares of the company’s stock worth $67,000 after buying an additional 2,508 shares during the last quarter.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on CV. Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a research note on Friday, November 14th. Wall Street Zen raised CapsoVision to a “hold” rating in a research report on Saturday, January 10th. Roth Mkm set a $7.00 price objective on CapsoVision in a research note on Tuesday, November 4th. Weiss Ratings reiterated a “sell (e)” rating on shares of CapsoVision in a research report on Monday, December 29th. Finally, Zacks Research raised shares of CapsoVision to a “hold” rating in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $6.00.
CapsoVision Stock Up 2.3%
Shares of NASDAQ:CV traded up $0.11 during trading on Friday, hitting $4.82. The stock had a trading volume of 43,414 shares, compared to its average volume of 420,118. CapsoVision has a 12-month low of $3.43 and a 12-month high of $15.37. The stock has a market capitalization of $225.77 million and a price-to-earnings ratio of -2.20. The stock has a 50-day simple moving average of $8.31 and a two-hundred day simple moving average of $5.88.
CapsoVision (NASDAQ:CV – Get Free Report) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The company had revenue of $3.54 million for the quarter.
About CapsoVision
CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.
In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.
Featured Stories
- Five stocks we like better than CapsoVision
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for CapsoVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CapsoVision and related companies with MarketBeat.com's FREE daily email newsletter.
